Folding@home
  • Download
  • Science
    • Covid-19
    • Diseases
    • Project Timeline
    • Papers & Results
    • Dig deeper
  • Support
    • User Guides
    • FAQ
    • Forum 🔗
    • Discord 🔗
  • Donate
    • USD via Folding@home Foundation 🔗
    • Crypto via Folding@home Foundation 🔗
    • DAF via Folding@home Foundation 🔗
    • Merchandise store 🔗
  • Data
  • Statistics
  • News
  • About
    • Gregory Bowman, PhD
    • The Folding@home Consortium (FAHC)
    • Contact us

Archives

Categories

  • Cancer
    • Breast Cancer
    • Epigenetics
    • Kidney Cancer
    • p53
  • Community
  • FAH achievements
  • FAH network connectivity
  • FAH team members
  • Folding@Home
  • Folding@home Blog
    • Meet the classic paper
  • General
  • Heads up
  • How FAH works
  • Infectious diseases
    • Chagas Disease
    • COVID-19
  • Neurological diseases
    • Alzheimer’s Disease
    • Huntington’s Disease
    • Parkinson’s Disease
  • Papers
  • Science
  • Software development
  • Timeline
  • Uncategorized
  • Web/Tech

Author: Greg Bowman

How does ApoE cause Alzheimer’s disease?

May 16, 2024 by Greg Bowman

A number of active projects on Folding@home right now aim to understand how different forms of the protein apolipoprotein E (ApoE) determine one’s risk of developing Alzheimer’s disease. Alzheimer’s disease…

Read more

AlphaFold opens new opportunities for Folding@home

May 2, 2024 by Greg Bowman

Folding@home has long sought to understand how proteins self-assemble, or fold, into their functional structures and what the functional implications of dynamics within the context of a folded protein are.…

Read more

New Folding@home software in beta

April 18, 2024 by Greg Bowman

The beta release of our new client software is going well. Thanks to everyone who has tried it out and given us feedback! If you haven’t already, you can download…

Read more

Unraveling the Mystery of Drug Specificity: The Case of Blebbistatin

November 30, 2023 by Greg Bowman

When it comes to designing novel drugs, achieving specificity is a major challenge. An effective drug must bind tightly to its target protein while avoiding unwanted side effects that can…

Read more

Unraveling the Secrets of G Protein Activation: A Molecular Odyssey

November 6, 2023 by Greg Bowman

G proteins are essential molecular players in the intricate symphony of cellular signaling. From our vision to our sense of smell, neurotransmission to cell growth, G proteins are at the…

Read more

2021 in review, and happy new year 2022

January 3, 2022 by Greg Bowman
World map showing global distribution of Folding@home users from Nature Chemistry 13:651–659, 2021 paper.

This past year, we have largely focused on following through on our commitment to take on SARS-CoV-2. Looking ahead, there’s more work to be done on the pandemic, and we…

Read more

Maximizing the impact of Folding@home by engaging industry collaborators

April 20, 2021 by Greg Bowman

For over 20 years, Folding@home has relied almost exclusively on government agencies like the National Science Foundation (NSF) and National Institutes of Health (NIH) for financial support. We’ve also been…

Read more

2020 in review, and happy new year 2021!

January 5, 2021 by Greg Bowman

TL;DR: During 2020, Folding@home was like the citizens’ fleet in the movie Star Wars: The Rise of Skywalker. Everyone came together to face a common foe, in this case the…

Read more

SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential

December 16, 2020 by Greg Bowman

As we all know, coronaviruses are a major threat to human health. In the past two decades these viruses have caused three epidemics: SARS in 2004, MERS in 2012, and…

Read more

Protein folding and related problems remain unsolved despite AlphaFold’s advance

December 8, 2020 by Greg Bowman
SARS-CoV-2 Visualization

TL;DR: DeepMind’s AlphaFold marks a tremendous advance in our ability to predict the dominant structure of a protein. How proteins get there, and many other problems related to protein folding,…

Read more

Posts navigation

< Older posts
Newer posts >